September 1, 2020
Yoshinao Mishima, president of the Japan Agency for Medical Research and Development (AMED), presented on August 28 his agency’s policies to steadily achieve the targets in the government’s second-term healthcare R&D promotion plan for FY2020-2024, saying, “Coordination and cooperation with...read more